Skye Bioscience (SKYE)

Skye Bioscience on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.

Download CSV

140K

Short interest

settlement 2026-10-15

4.9

Days to cover

+3.2 days vs prior

25.0%

Short share of volume

2026-11-02

4,747

Fails to deliver

settlement 2026-10-08

Mon 9 Nov

Next earnings

estimated date

-$889K

Insider flow, 90 days

0 buys, 30 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in SKYE is 140,313 shares, up 23,227 shares over the last month. Over the last 48 readings it ranged from 117,086 shares (15 September 2026) to 3,302,228 shares (30 April 2025). The latest reading sits at the bottom of that range. At the reported average volume of 29K shares a day that is 4.9 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/skye" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	140,313	-5.2%	28,640	4.90
2026-09-30	147,954	+26.4%	85,208	1.74
2026-09-15	117,086	-9.1%	86,091	1.36
2026-08-31	128,781	-89.3%	217,817	1.00
2026-08-14	1,203,600	-8.6%	799,341	1.51
2026-07-31	1,316,797	+24.9%	104,833	12.56
2026-07-15	1,054,357	+10.9%	132,231	7.97
2026-06-30	950,654	-2.5%	133,002	7.15
2026-06-15	974,765	-13.5%	202,290	4.82
2026-05-29	1,126,334	-11.2%	170,323	6.61
2026-05-15	1,268,178	-1.3%	175,331	7.23
2026-04-30	1,284,390	-11.9%	244,960	5.24
2026-04-15	1,458,232	-8.8%	197,723	7.38
2026-03-31	1,598,033	+1.6%	231,135	6.91
2026-03-13	1,573,477	+62.6%	1,961,638	1.00
2026-02-27	967,400	+5.0%	201,653	4.80
2026-02-13	921,289	-9.2%	412,735	2.23
2026-01-30	1,014,976	+6.3%	169,503	5.99
2026-01-15	954,593	-4.4%	516,165	1.85
2025-12-31	998,730	-7.2%	695,830	1.44
2025-12-15	1,076,346	+1.4%	268,008	4.02
2025-11-28	1,061,071	-31.0%	263,481	4.03
2025-11-14	1,537,748	-21.3%	308,194	4.99
2025-10-31	1,952,988	-16.3%	546,922	3.57
2025-10-15	2,333,871	-21.1%	2,904,441	1.00
2025-09-30	2,957,160	+7.7%	366,715	8.06
2025-09-15	2,745,750	+0.3%	398,756	6.89
2025-08-29	2,738,188	+2.6%	210,394	13.01
2025-08-15	2,669,234	-1.4%	345,125	7.73
2025-07-31	2,707,697	+1.1%	346,950	7.80
2025-07-15	2,679,063	+0.2%	842,323	3.18
2025-06-30	2,674,088	-5.1%	3,531,707	1.00
2025-06-13	2,816,636	-9.5%	244,638	11.51
2025-05-30	3,113,413	-3.1%	242,592	12.83
2025-05-15	3,212,389	-2.7%	208,464	15.41
2025-04-30	3,302,228	+23.8%	491,021	6.73
2025-04-15	2,666,837	+16.9%	2,664,954	1.00
2025-03-31	2,281,239	+11.0%	287,312	7.94
2025-03-14	2,055,376	-5.1%	120,961	16.99
2025-02-28	2,166,767	+6.2%	161,310	13.43
2025-02-14	2,040,506	+13.5%	196,398	10.39
2025-01-31	1,797,243	-5.4%	213,914	8.40
2025-01-15	1,899,534	+10.4%	112,823	16.84
2024-12-31	1,720,770	-2.7%	209,100	8.23
2024-12-13	1,768,109	+11.3%	219,653	8.05
2024-11-29	1,588,330	-20.3%	132,967	11.95
2024-11-15	1,992,030	+27.1%	175,824	11.33
2024-10-31	1,567,022	+10.6%	224,504	6.98

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of SKYE volume is 25.0%, up 15.8 points over the last five sessions. Over the last 30 readings it ranged from 7.0% (7 October 2026) to 61.6% (13 October 2026). The latest reading is in line with the 30-session average of 26.4%, on 5K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	1K	5K	25.0%	0
2026-10-30	3K	15K	19.3%	2
2026-10-29	3K	12K	21.8%	0
2026-10-28	3K	7K	46.1%	0
2026-10-27	3K	10K	27.5%	0
2026-10-26	940	10K	9.2%	0
2026-10-23	2K	8K	24.2%	0
2026-10-22	2K	13K	12.3%	0
2026-10-21	2K	6K	24.6%	0
2026-10-20	1K	3K	32.6%	0
2026-10-19	4K	7K	58.3%	0
2026-10-16	4K	11K	36.7%	0
2026-10-15	2K	6K	28.7%	0
2026-10-14	2K	13K	16.5%	0
2026-10-13	6K	10K	61.6%	0
2026-10-12	9K	19K	49.3%	0
2026-10-09	2K	7K	20.6%	0
2026-10-08	296	4K	7.8%	0
2026-10-07	2K	24K	7.0%	0
2026-10-06	2K	16K	15.6%	0
2026-10-05	4K	19K	21.3%	0
2026-10-02	545	2K	28.2%	0
2026-10-01	3K	11K	23.2%	0
2026-09-30	16K	56K	29.5%	0
2026-09-29	12K	30K	38.0%	0
2026-09-28	2K	12K	20.2%	0
2026-09-25	6K	20K	29.9%	0
2026-09-24	4K	17K	24.6%	0
2026-09-23	11K	151K	7.2%	300
2026-09-22	13K	55K	24.1%	0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 8 October 2026, the fails-to-deliver balance in SKYE is 4,747 shares, up 3,280 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (2 October 2026) to 48,599 shares (29 July 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-08	4,747	$1.65	$8K
2026-10-07	1,467	$1.62	$2K
2026-10-02	1	$1.60	$2
2026-09-25	351	$1.70	$597
2026-09-24	10,503	$1.80	$19K
2026-09-23	11,591	$1.71	$20K
2026-09-21	136	$1.77	$241
2026-09-08	27,863	$1.86	$52K
2026-09-04	12,223	$1.78	$22K
2026-09-03	13,893	$1.84	$26K
2026-09-02	1,866	$1.80	$3K
2026-09-01	118	$1.68	$198
2026-08-27	166	$2.02	$335
2026-08-26	3	$2.03	$6
2026-08-25	12,282	$2.13	$26K
2026-08-21	47,273	$0.28	$13K
2026-08-18	19,649	$0.42	$8K
2026-08-12	3,331	$0.54	$2K
2026-08-11	2,520	$0.53	$1K
2026-08-06	2,020	$0.56	$1K
2026-07-30	39,615	$0.62	$25K
2026-07-29	48,599	$0.62	$30K
2026-07-28	15,604	$0.62	$10K
2026-07-23	5,425	$0.64	$3K
2026-07-22	5	$0.64	$3
2026-07-14	5,620	$0.66	$4K
2026-07-13	5,211	$0.69	$4K
2026-07-07	33,430	$0.70	$23K
2026-07-06	36,798	$0.70	$26K
2026-07-01	11,344	$0.69	$8K

Insider trades

SEC Form 4, newest first. JSON

Insiders at SKYE reported 30 open-market sells worth $889K in the last 90 days and no open-market buys. Latest filing: Schwab Andrew J. (Director, 10% owner) on 2026-09-23.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-09-23	Schwab Andrew J.	Director, 10% owner	Sell	5K	$1.61	$7K	0
2026-09-23	Schwab Andrew J.	Director, 10% owner	Sell	115K	$1.61	$185K	0
2026-09-23	5AM Partners VII, LLC	10% owner	Sell	5K	$1.61	$7K	0
2026-09-23	5AM Partners VII, LLC	10% owner	Sell	115K	$1.61	$185K	0
2026-09-22	Schwab Andrew J.	Director, 10% owner	Sell	1K	$1.65	$2K	5K
2026-09-22	Schwab Andrew J.	Director, 10% owner	Sell	28K	$1.65	$46K	115K
2026-09-22	5AM Partners VII, LLC	10% owner	Sell	1K	$1.65	$2K	5K
2026-09-22	5AM Partners VII, LLC	10% owner	Sell	28K	$1.65	$46K	115K
2026-09-16	5AM Partners VII, LLC	10% owner	Sell	1K	$1.91	$2K	6K
2026-09-16	5AM Partners VII, LLC	10% owner	Sell	33K	$1.91	$62K	142K
2026-09-16	Schwab Andrew J.	Director, 10% owner	Sell	1K	$1.91	$2K	6K
2026-09-16	Schwab Andrew J.	Director, 10% owner	Sell	33K	$1.91	$62K	142K
2026-08-20	Schwab Andrew J.	Director, 10% owner	Sell	6K	$0.32	$2K	7.9M
2026-08-20	Schwab Andrew J.	Director, 10% owner	Sell	46	$0.32	$15	55K
2026-08-20	Schwab Andrew J.	Director, 10% owner	Sell	1K	$0.32	$371	1.4M
2026-08-20	5AM Partners VII, LLC	10% owner	Sell	6K	$0.32	$2K	7.9M
2026-08-20	5AM Partners VII, LLC	10% owner	Sell	46	$0.32	$15	55K
2026-08-20	5AM Partners VII, LLC	10% owner	Sell	1K	$0.32	$371	1.4M
2026-08-19	Schwab Andrew J.	Director, 10% owner	Sell	57K	$0.35	$20K	7.9M
2026-08-19	Schwab Andrew J.	Director, 10% owner	Sell	409	$0.35	$143	55K
2026-08-19	Schwab Andrew J.	Director, 10% owner	Sell	10K	$0.35	$4K	1.4M
2026-08-19	5AM Partners VII, LLC	10% owner	Sell	57K	$0.35	$20K	7.9M
2026-08-19	5AM Partners VII, LLC	10% owner	Sell	409	$0.35	$143	55K
2026-08-19	5AM Partners VII, LLC	10% owner	Sell	10K	$0.35	$4K	1.4M
2026-08-18	Schwab Andrew J.	Director, 10% owner	Sell	253K	$0.38	$96K	7.9M
2026-08-18	Schwab Andrew J.	Director, 10% owner	Sell	2K	$0.38	$695	56K
2026-08-18	Schwab Andrew J.	Director, 10% owner	Sell	45K	$0.38	$17K	1.4M
2026-08-18	5AM Partners VII, LLC	10% owner	Sell	253K	$0.38	$96K	7.9M
2026-08-18	5AM Partners VII, LLC	10% owner	Sell	2K	$0.38	$695	56K
2026-08-18	5AM Partners VII, LLC	10% owner	Sell	45K	$0.38	$17K	1.4M
2026-08-07	DHILLON PUNIT	Chief Executive Officer	Grant	1.1M	$0.00	$0	1.4M
2025-08-22	ROCKLAGE SCOTT M	TenPercentOwner	Sell	164K	$3.42	$561K	1.5M
2025-08-22	ROCKLAGE SCOTT M	TenPercentOwner	Sell	6K	$3.42	$22K	57K
2025-08-22	Schwab Andrew J.	Director, 10% owner	Sell	6K	$3.42	$22K	57K
2025-08-22	Schwab Andrew J.	Director, 10% owner	Sell	164K	$3.42	$561K	1.5M
2025-08-22	5AM Partners VII, LLC	10% owner	Sell	6K	$3.42	$22K	57K
2025-08-22	5AM Partners VII, LLC	10% owner	Sell	164K	$3.42	$561K	1.5M
2025-08-21	ROCKLAGE SCOTT M	TenPercentOwner	Sell	2K	$3.57	$8K	64K
2025-08-21	ROCKLAGE SCOTT M	TenPercentOwner	Sell	59K	$3.57	$209K	1.6M
2025-08-21	Schwab Andrew J.	Director, 10% owner	Sell	2K	$3.57	$8K	64K
2025-08-21	Schwab Andrew J.	Director, 10% owner	Sell	59K	$3.57	$209K	1.6M
2025-08-21	5AM Partners VII, LLC	10% owner	Sell	2K	$3.57	$8K	64K
2025-08-21	5AM Partners VII, LLC	10% owner	Sell	59K	$3.57	$209K	1.6M
2024-11-18	ARSENAULT KAITLYN	Chief Financial Officer	Sell	43K	$4.99	$215K	168K
2024-11-18	Grayson Paul A.	Director	Sell	86K	$4.99	$430K	260K
2024-11-18	DHILLON PUNIT	Chief Executive Officer	Sell	83K	$4.99	$412K	330K
2024-11-18	ARSENAULT KAITLYN	Chief Financial Officer	Sell	43K	$4.99	$216K	166K
2024-11-18	Diep Tuan Tu	Chief Development Officer	Sell	19K	$4.99	$97K	82K
2024-11-15	ARSENAULT KAITLYN	Chief Financial Officer	Sell	190	$5.55	$1K	211K
2024-11-15	Grayson Paul A.	Director	Sell	307	$5.55	$2K	346K
2024-11-15	DHILLON PUNIT	Chief Executive Officer	Sell	364	$5.55	$2K	412K
2024-11-15	ARSENAULT KAITLYN	Chief Financial Officer	Sell	190	$5.55	$1K	210K
2024-11-15	Diep Tuan Tu	Chief Development Officer	Sell	85	$5.55	$472	102K
2024-09-13	5AM Ventures VII, L.P.	TenPercentOwner	Sell	79	$6.06	$479	66K
2024-09-13	5AM Ventures VII, L.P.	TenPercentOwner	Sell	2K	$6.06	$12K	1.7M
2024-09-13	5AM Ventures VII, L.P.	TenPercentOwner	Sell	12K	$6.06	$71K	8.2M
2024-09-13	Schwab Andrew J.	Director,TenPercentOwner	Sell	12K	$6.06	$71K	8.2M
2024-09-13	Schwab Andrew J.	Director,TenPercentOwner	Sell	2K	$6.06	$12K	1.7M
2024-09-13	Schwab Andrew J.	Director,TenPercentOwner	Sell	79	$6.06	$479	66K
2024-09-11	5AM Ventures VII, L.P.	TenPercentOwner	Sell	37K	$6.60	$241K	1.7M
2024-09-11	5AM Ventures VII, L.P.	TenPercentOwner	Sell	215K	$6.60	$1.4M	8.2M
2024-09-11	5AM Ventures VII, L.P.	TenPercentOwner	Sell	1K	$6.60	$10K	66K
2024-09-11	Schwab Andrew J.	Director,TenPercentOwner	Sell	1K	$6.60	$10K	66K
2024-09-11	Schwab Andrew J.	Director,TenPercentOwner	Sell	37K	$6.60	$241K	1.7M
2024-09-11	Schwab Andrew J.	Director,TenPercentOwner	Sell	215K	$6.60	$1.4M	8.2M
2024-08-26	DHILLON PUNIT	Chief Executive Officer	Other transaction	16K	price not stated in the filing	not stated	413K
2024-03-13	Schwab Andrew J.	Director,TenPercentOwner	Grant	450K	$10.00	$4.5M	8.4M
2024-03-13	PARMAR KUSH	TenPercentOwner	Buy	450K	$10.00	$4.5M	8.4M
2024-02-29	ARSENAULT KAITLYN	Chief Financial Officer	Grant	25K	$0.00	$0	211K
2024-02-29	DHILLON PUNIT	Chief Executive Officer	Grant	100K	$0.00	$0	397K
2024-02-29	ARSENAULT KAITLYN	Chief Financial Officer	Grant	25K	$0.00	$0	210K
2024-02-29	Diep Tuan Tu	Chief Development Officer	Grant	25K	$0.00	$0	102K
2024-02-29	Grayson Paul A.	Director	Grant	100K	$0.00	$0	346K
2024-01-31	DIEKMAN JOHN D	TenPercentOwner	Buy	5.2M	$2.31	$12.0M	7.9M
2024-01-31	Schwab Andrew J.	Director,TenPercentOwner	Grant	5.2M	$2.31	$12.0M	7.9M
2023-11-06	Grayson Paul A.	Director	Grant	174K	$0.00	$0	246K
2023-11-06	DHILLON PUNIT	Chief Executive Officer	Grant	194K	$0.00	$0	297K
2023-11-06	ARSENAULT KAITLYN	Chief Financial Officer	Grant	128K	$0.00	$0	186K
2023-08-29	DHILLON PUNIT	Chief Executive Officer	Buy	881K	$0.02	$18K	41.6M
2023-08-29	DHILLON PUNIT	Chief Executive Officer	Buy	881K	$0.02	$18K	25.7M
2023-08-28	DHILLON PUNIT	Chief Executive Officer	Small acquisition	110K	$0.02	$2K	40.7M
2023-08-28	DHILLON PUNIT	Chief Executive Officer	Small acquisition	110K	$0.02	$2K	24.8M
2023-08-25	DHILLON PUNIT	Chief Executive Officer	Grant	20.3M	price not stated in the filing	not stated	40.6M
2023-08-25	ARSENAULT KAITLYN	Chief Financial Officer	Grant	13.4M	$0.00	$0	14.4M
2023-08-25	Grayson Paul A.	Director	Grant	18.1M	price not stated in the filing	not stated	18.1M
2023-08-25	DHILLON PUNIT	Chief Executive Officer	Grant	20.3M	price not stated in the filing	not stated	24.7M
2023-08-23	DHILLON PUNIT	Chief Executive Officer	Small acquisition	9K	$0.01	$90	40.6M
2023-08-23	DHILLON PUNIT	Chief Executive Officer	Small acquisition	9K	$0.01	$90	24.7M
2023-08-18	Schwab Andrew J.	Director,TenPercentOwner	Grant	267.6M	price not stated in the filing	not stated	267.6M
2023-08-18	Schwab Andrew J.	Director,TenPercentOwner	Grant	6.4M	$0.01	$64K	16.9M
2023-08-18	Schwab Andrew J.	Director,TenPercentOwner	Grant	161.9M	$0.01	$1.6M	429.5M
2023-08-18	Schwab Andrew J.	Director,TenPercentOwner	Grant	684.4M	$0.01	$6.8M	684.4M
2023-08-18	Schwab Andrew J.	Director,TenPercentOwner	Grant	10.6M	price not stated in the filing	not stated	10.6M
2023-02-22	Emerald Health Sciences Inc.	TenPercentOwner	Grant	41.4M	$0.04	$1.7M	169.4M
2023-02-22	Emerald Health Sciences Inc.	TenPercentOwner	Grant	16.6M	$0.02	$333K	128.0M
2022-11-10	Rai Sukhwinder Singh	Director	Grant	74K	price not stated in the filing	not stated	74K
2022-11-10	Rai Sukhwinder Singh	Director	Grant	22K	price not stated in the filing	not stated	22K
2022-11-10	DHILLON PUNIT	Chief Executive Officer	Grant	1.4M	price not stated in the filing	not stated	4.4M
2022-11-10	DHILLON PUNIT	Chief Executive Officer	Grant	2.3M	price not stated in the filing	not stated	2.3M
2021-12-14	Arsenault Kaitlyn Melanie	Chief Financial Officer	Grant	1.0M	price not stated in the filing	not stated	1.0M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

6 holders report 5% or more of SKYE in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is Andrew J. Schwab at 26.1% of the class (1,218,088 shares), filed 2026-09-24 for an event on 2026-09-22.

Filed	Form	Holder	Shares	Of class	Event
2026-10-14	13G	TANG CAPITAL MANAGEMENT, LLCother entity	264K	6.0%	2026-10-07
2026-10-14	13G	KEVIN TANGindividual	264K	6.0%	2026-10-07
2026-10-14	13G	TANG CAPITAL PARTNERS INTERNATIONAL, LPpartnership	84K	1.8%	2026-10-07
2026-10-14	13G	TANG CAPITAL PARTNERS IV, INCcorporation	60K	1.4%	2026-10-07
2026-10-14	13G	TANG CAPITAL PARTNERS, LPpartnership	60K	1.4%	2026-10-07
2026-10-14	13G	TANG CAPITAL PARTNERS III, INCcorporation	60K	1.4%	2026-10-07
2026-09-24	13D/Ano. 6	Andrew J. Schwabindividual	1.2M	26.1%	2026-09-22
2026-09-24	13D/Ano. 6	Kush Parmarindividual	1.2M	25.7%	2026-09-22
2026-09-24	13D/Ano. 6	5AM Ventures VII, L.P.partnership	1.2M	25.7%	2026-09-22
2026-09-24	13D/Ano. 6	5AM Partners VII, LLCother entity	1.2M	25.7%	2026-09-22
2026-09-24	13D/Ano. 6	5AM Partners II, LLCother entity	0	0.0%	2026-09-22
2026-09-24	13D/Ano. 6	Scott M. Rocklageindividual	0	0.0%	2026-09-22
2026-09-24	13D/Ano. 6	John D. Diekmanindividual	0	0.0%	2026-09-22
2026-09-24	13D/Ano. 6	5AM Co-Investors II, L.P.partnership	0	0.0%	2026-09-22
2026-09-24	13D/Ano. 6	5AM Ventures II, L.P.partnership	0	0.0%	2026-09-22

13F holders

Tracked managers holding SKYE at their latest 13F. JSON

1 of the 30 tracked managers held SKYE at their latest 13F, $138K in total at quarter-end prices. Millennium Management is the largest at $138K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 1 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Millennium Management	2026-06-30	199K	$138K	0.00%	-60K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Skye Bioscience in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Skye Bioscience (SKYE), SEC CIK 1516551, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-08.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-14.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2025-11-10.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-23.JSON and CSV
Company record: EDGAR filing index for CIK 1516551Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as pharmaceutical preparations

Other company pages

Datasets

Frequently Asked Questions

How much of SKYE is sold short?

140,313 shares were held short at the 2026-10-15 settlement, 4.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is SKYE's daily short volume?

On 2026-11-02, 1,286 of the 5,141 SKYE shares reported to FINRA were sold short, 25.0% of the day's reported volume. Short volume is a flow for one day, not a position.

Does SKYE have fails to deliver?

The SEC's latest file shows 4,747 SKYE shares failed to deliver at settlement 2026-10-08. Fails are reported per settlement date and published twice a month with a lag.

Are SKYE insiders buying or selling?

Insiders at SKYE reported 30 open-market sells worth $889K in the last 90 days and no open-market buys. Latest filing: Schwab Andrew J. (Director, 10% owner) on 2026-09-23.

Who owns 5% or more of SKYE?

Which tracked 13F managers own SKYE?

1 of the 30 tracked 13F managers held SKYE shares at their latest filing, $138K in all. The largest: Izzy Englander's Millennium Management (199K shares, $138K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.